FINV vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FINV presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 6/9 and an extreme valuation discount. The stock trades significantly below its Graham Number ($17.59) and Intrinsic Value ($9.87), with a P/B of 0.49 and a P/E of 3.41. While YoY revenue and earnings growth are sharply negative, the company maintains an exceptionally strong balance sheet with negligible debt (D/E 0.08) and high liquidity (Current Ratio 9.38). The bullish outlook is driven by the massive margin of safety and a sustainable 6.36% dividend yield.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FINV vs JPM: Head-to-Head Comparison
This page compares FinVolution Group (FINV) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.